KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Account Payables (2020 - 2023)

Historic Change in Account Payables for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q2 2023 value amounting to -$6.7 million.

  • Ginkgo Bioworks Holdings' Change in Account Payables rose 5714.1% to -$6.7 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$18.5 million, marking a year-over-year decrease of 21766.09%. This contributed to the annual value of $4.8 million for FY2024, which is 50329.67% up from last year.
  • Ginkgo Bioworks Holdings' Change in Account Payables amounted to -$6.7 million in Q2 2023, which was up 5714.1% from $9.7 million recorded in Q1 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Change in Account Payables peaked at $26.2 million during Q1 2022, and registered a low of -$15.6 million during Q2 2022.
  • In the last 4 years, Ginkgo Bioworks Holdings' Change in Account Payables had a median value of $516000.0 in 2021 and averaged -$525363.6.
  • Over the last 5 years, Ginkgo Bioworks Holdings' Change in Account Payables had its largest YoY gain of 498720.93% in 2022, and its largest YoY loss of 291240.46% in 2022.
  • Over the past 4 years, Ginkgo Bioworks Holdings' Change in Account Payables (Quarter) stood at $4.3 million in 2020, then tumbled by 87.87% to $524000.0 in 2021, then tumbled by 2912.4% to -$14.7 million in 2022, then soared by 54.63% to -$6.7 million in 2023.
  • Its Change in Account Payables was -$6.7 million in Q2 2023, compared to $9.7 million in Q1 2023 and -$14.7 million in Q4 2022.